nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE7A—kidney—metabolic syndrome X	0.0678	0.149	CbGeAlD
Flavoxate—PDE7B—adipose tissue—metabolic syndrome X	0.0534	0.117	CbGeAlD
Flavoxate—PDE8B—adipose tissue—metabolic syndrome X	0.0425	0.0932	CbGeAlD
Flavoxate—PDE8A—adipose tissue—metabolic syndrome X	0.0382	0.0839	CbGeAlD
Flavoxate—PDE7B—liver—metabolic syndrome X	0.0374	0.0821	CbGeAlD
Flavoxate—PDE4D—adipose tissue—metabolic syndrome X	0.0347	0.076	CbGeAlD
Flavoxate—PDE4A—adipose tissue—metabolic syndrome X	0.0307	0.0672	CbGeAlD
Flavoxate—PDE8B—liver—metabolic syndrome X	0.0298	0.0654	CbGeAlD
Flavoxate—PDE8A—liver—metabolic syndrome X	0.0268	0.0588	CbGeAlD
Flavoxate—Antrafenine—PTGS2—metabolic syndrome X	0.026	1	CrCbGaD
Flavoxate—PDE4D—liver—metabolic syndrome X	0.0243	0.0533	CbGeAlD
Flavoxate—CHRM2—cardiovascular system—metabolic syndrome X	0.0206	0.0452	CbGeAlD
Flavoxate—CHRM1—cardiovascular system—metabolic syndrome X	0.0187	0.0411	CbGeAlD
Flavoxate—PDE4B—adipose tissue—metabolic syndrome X	0.0183	0.0401	CbGeAlD
Flavoxate—PDE4B—liver—metabolic syndrome X	0.0128	0.0281	CbGeAlD
Flavoxate—PDE8A—Signaling Pathways—IGF1—metabolic syndrome X	0.000699	0.00135	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IGF1—metabolic syndrome X	0.000699	0.00135	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HTR2C—metabolic syndrome X	0.000697	0.00135	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—APOA1—metabolic syndrome X	0.000692	0.00134	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AGT—metabolic syndrome X	0.000687	0.00133	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—APOC3—metabolic syndrome X	0.00068	0.00131	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CYBA—metabolic syndrome X	0.000675	0.0013	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IRS1—metabolic syndrome X	0.000672	0.0013	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AGT—metabolic syndrome X	0.000666	0.00129	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000665	0.00128	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000663	0.00128	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000663	0.00128	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000663	0.00128	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—GHRL—metabolic syndrome X	0.000661	0.00128	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000656	0.00127	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AGT—metabolic syndrome X	0.000653	0.00126	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—CCL2—metabolic syndrome X	0.00065	0.00125	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—INS—metabolic syndrome X	0.000644	0.00124	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CYBA—metabolic syndrome X	0.000642	0.00124	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NOS3—metabolic syndrome X	0.000633	0.00122	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NOS3—metabolic syndrome X	0.000633	0.00122	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CCL2—metabolic syndrome X	0.000633	0.00122	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000631	0.00122	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GHRL—metabolic syndrome X	0.000629	0.00121	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CNR1—metabolic syndrome X	0.000626	0.00121	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IRS1—metabolic syndrome X	0.000625	0.00121	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IGF1—metabolic syndrome X	0.000623	0.0012	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000623	0.0012	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HTR2C—metabolic syndrome X	0.000614	0.00118	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CCL5—metabolic syndrome X	0.000605	0.00117	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AGT—metabolic syndrome X	0.000605	0.00117	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—INS—metabolic syndrome X	0.000598	0.00116	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CCL5—metabolic syndrome X	0.000597	0.00115	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CNR1—metabolic syndrome X	0.000595	0.00115	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CYBA—metabolic syndrome X	0.000594	0.00115	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000591	0.00114	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CCL2—metabolic syndrome X	0.000589	0.00114	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IGF2—metabolic syndrome X	0.000587	0.00113	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GHRL—metabolic syndrome X	0.000582	0.00112	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IGF1—metabolic syndrome X	0.000579	0.00112	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000573	0.00111	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—APOB—metabolic syndrome X	0.00057	0.0011	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—CCL2—metabolic syndrome X	0.000565	0.00109	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000565	0.00109	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NOS3—metabolic syndrome X	0.000564	0.00109	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CCL5—metabolic syndrome X	0.000557	0.00108	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000555	0.00107	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CNR1—metabolic syndrome X	0.000551	0.00106	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.00055	0.00106	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000547	0.00106	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—LPL—metabolic syndrome X	0.000545	0.00105	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000543	0.00105	CbGpPWpGaD
Flavoxate—PDE8A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000543	0.00105	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00054	0.00104	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000538	0.00104	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—IL6—metabolic syndrome X	0.000534	0.00103	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—IL6—metabolic syndrome X	0.000534	0.00103	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NOS3—metabolic syndrome X	0.000525	0.00101	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.000519	0.001	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IGF2—metabolic syndrome X	0.000511	0.000987	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—AGT—metabolic syndrome X	0.000506	0.000977	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—AGT—metabolic syndrome X	0.0005	0.000964	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—CCL2—metabolic syndrome X	0.000498	0.000961	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—APOB—metabolic syndrome X	0.000496	0.000959	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—AKT1—metabolic syndrome X	0.000493	0.000951	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000493	0.000951	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000491	0.000949	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IGF2—metabolic syndrome X	0.000487	0.00094	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000485	0.000936	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCL5—metabolic syndrome X	0.000485	0.000936	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000484	0.000934	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000483	0.000933	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—IL6—metabolic syndrome X	0.000476	0.000919	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—LPL—metabolic syndrome X	0.000474	0.000915	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—APOB—metabolic syndrome X	0.000473	0.000912	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AGT—metabolic syndrome X	0.000466	0.0009	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000466	0.000899	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCL5—metabolic syndrome X	0.000461	0.000891	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00046	0.000888	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00046	0.000888	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—LEP—metabolic syndrome X	0.000456	0.000881	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—APOE—metabolic syndrome X	0.000456	0.000881	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—APOA1—metabolic syndrome X	0.000451	0.000871	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—LPL—metabolic syndrome X	0.000451	0.000871	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IGF2—metabolic syndrome X	0.00045	0.00087	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.00045	0.000868	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000446	0.000861	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—IL6—metabolic syndrome X	0.000443	0.000855	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000441	0.000852	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00044	0.00085	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—AKT1—metabolic syndrome X	0.000439	0.000848	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—APOB—metabolic syndrome X	0.000437	0.000844	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000435	0.000841	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCL5—metabolic syndrome X	0.000427	0.000824	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000425	0.000821	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GHRL—metabolic syndrome X	0.000423	0.000817	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.000419	0.000809	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TGFB1—metabolic syndrome X	0.000419	0.000809	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000419	0.000809	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GHRL—metabolic syndrome X	0.000418	0.000806	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—LPL—metabolic syndrome X	0.000418	0.000806	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CCL2—metabolic syndrome X	0.000417	0.000805	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CCL2—metabolic syndrome X	0.000411	0.000794	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000408	0.000788	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IRS1—metabolic syndrome X	0.000407	0.000786	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AGT—metabolic syndrome X	0.000406	0.000783	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CNR1—metabolic syndrome X	0.000401	0.000773	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—APOE—metabolic syndrome X	0.000397	0.000767	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—LEP—metabolic syndrome X	0.000397	0.000767	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CNR1—metabolic syndrome X	0.000395	0.000763	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—APOA1—metabolic syndrome X	0.000393	0.000758	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—INS—metabolic syndrome X	0.00039	0.000753	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AGT—metabolic syndrome X	0.000386	0.000745	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CCL2—metabolic syndrome X	0.000384	0.000741	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HDAC3—metabolic syndrome X	0.000378	0.000731	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—LEP—metabolic syndrome X	0.000378	0.00073	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—APOE—metabolic syndrome X	0.000378	0.00073	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IGF1—metabolic syndrome X	0.000377	0.000728	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—APOA1—metabolic syndrome X	0.000374	0.000722	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HDAC3—metabolic syndrome X	0.000374	0.000721	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TGFB1—metabolic syndrome X	0.000373	0.000721	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000358	0.000692	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AGT—metabolic syndrome X	0.000357	0.00069	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IRS1—metabolic syndrome X	0.000354	0.000684	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—APOE—metabolic syndrome X	0.00035	0.000676	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—LEP—metabolic syndrome X	0.00035	0.000676	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000347	0.00067	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—IL6—metabolic syndrome X	0.000346	0.000669	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—APOA1—metabolic syndrome X	0.000346	0.000668	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NOS3—metabolic syndrome X	0.000342	0.00066	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000342	0.00066	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—INS—metabolic syndrome X	0.000339	0.000655	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000338	0.000653	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000337	0.000652	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IRS1—metabolic syndrome X	0.000337	0.000651	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCL2—metabolic syndrome X	0.000334	0.000645	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000334	0.000645	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TRIB3—metabolic syndrome X	0.00033	0.000637	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RBP4—metabolic syndrome X	0.00033	0.000637	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IGF1—metabolic syndrome X	0.000328	0.000634	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.000328	0.000634	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RBP4—metabolic syndrome X	0.000325	0.000628	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TRIB3—metabolic syndrome X	0.000325	0.000628	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—INS—metabolic syndrome X	0.000323	0.000624	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCL2—metabolic syndrome X	0.000318	0.000614	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL6—metabolic syndrome X	0.000316	0.000609	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL6—metabolic syndrome X	0.000316	0.000609	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IGF1—metabolic syndrome X	0.000313	0.000603	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IRS1—metabolic syndrome X	0.000312	0.000603	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000312	0.000602	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL5—metabolic syndrome X	0.00031	0.000599	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000309	0.000597	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL5—metabolic syndrome X	0.000306	0.000592	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000305	0.000589	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—INS—metabolic syndrome X	0.000299	0.000577	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NOS3—metabolic syndrome X	0.000298	0.000575	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000297	0.000573	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCL2—metabolic syndrome X	0.000294	0.000568	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000293	0.000566	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOC3—metabolic syndrome X	0.000292	0.000564	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—AKT1—metabolic syndrome X	0.000291	0.000562	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—AKT1—metabolic syndrome X	0.000291	0.000562	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IGF1—metabolic syndrome X	0.000289	0.000558	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL6—metabolic syndrome X	0.000288	0.000557	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOC3—metabolic syndrome X	0.000288	0.000557	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AGT—metabolic syndrome X	0.000286	0.000552	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOS3—metabolic syndrome X	0.000283	0.000547	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AGT—metabolic syndrome X	0.000282	0.000545	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL6—metabolic syndrome X	0.000281	0.000543	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000275	0.00053	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—AKT1—metabolic syndrome X	0.000266	0.000514	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000264	0.000509	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOS3—metabolic syndrome X	0.000262	0.000506	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL6—metabolic syndrome X	0.000261	0.000505	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR2C—metabolic syndrome X	0.00026	0.000502	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AGT—metabolic syndrome X	0.00026	0.000501	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—AKT1—metabolic syndrome X	0.000259	0.000501	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AGT—metabolic syndrome X	0.000256	0.000495	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CYBA—metabolic syndrome X	0.000255	0.000493	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000255	0.000493	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CYBA—metabolic syndrome X	0.000252	0.000487	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL6—metabolic syndrome X	0.000251	0.000485	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GHRL—metabolic syndrome X	0.00025	0.000482	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GHRL—metabolic syndrome X	0.000247	0.000476	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000243	0.000469	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—AKT1—metabolic syndrome X	0.000241	0.000466	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL6—metabolic syndrome X	0.000239	0.000461	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CNR1—metabolic syndrome X	0.000237	0.000457	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CNR1—metabolic syndrome X	0.000234	0.000451	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AKT1—metabolic syndrome X	0.000232	0.000447	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TGFB1—metabolic syndrome X	0.000226	0.000437	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000225	0.000434	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6—metabolic syndrome X	0.000221	0.000427	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000221	0.000426	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000214	0.000413	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL2—metabolic syndrome X	0.000211	0.000408	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AKT1—metabolic syndrome X	0.000204	0.000394	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TGFB1—metabolic syndrome X	0.000197	0.00038	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF2—metabolic syndrome X	0.000193	0.000374	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF2—metabolic syndrome X	0.000191	0.000369	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOB—metabolic syndrome X	0.000188	0.000363	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000187	0.000362	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOB—metabolic syndrome X	0.000185	0.000358	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL5—metabolic syndrome X	0.000183	0.000354	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000183	0.000353	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL5—metabolic syndrome X	0.000181	0.00035	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00018	0.000348	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LPL—metabolic syndrome X	0.000179	0.000346	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LPL—metabolic syndrome X	0.000177	0.000342	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TGFB1—metabolic syndrome X	0.000173	0.000335	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6—metabolic syndrome X	0.00017	0.000329	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AKT1—metabolic syndrome X	0.000157	0.000304	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AGT—metabolic syndrome X	0.000153	0.000296	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AGT—metabolic syndrome X	0.000151	0.000292	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LEP—metabolic syndrome X	0.00015	0.00029	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOE—metabolic syndrome X	0.00015	0.00029	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOA1—metabolic syndrome X	0.000149	0.000287	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LEP—metabolic syndrome X	0.000148	0.000286	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOE—metabolic syndrome X	0.000148	0.000286	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6—metabolic syndrome X	0.000148	0.000286	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOA1—metabolic syndrome X	0.000147	0.000283	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6—metabolic syndrome X	0.000141	0.000273	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AKT1—metabolic syndrome X	0.000137	0.000264	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	0.000134	0.000259	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	0.000132	0.000256	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6—metabolic syndrome X	0.000131	0.000252	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AKT1—metabolic syndrome X	0.00013	0.000251	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—INS—metabolic syndrome X	0.000128	0.000248	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—INS—metabolic syndrome X	0.000127	0.000245	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	0.000126	0.000244	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	0.000125	0.000241	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	0.000124	0.00024	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	0.000123	0.000237	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AKT1—metabolic syndrome X	0.000121	0.000233	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000118	0.000228	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000116	0.000225	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	0.000113	0.000217	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	0.000111	0.000215	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	9.65e-05	0.000186	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	9.53e-05	0.000184	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	9.5e-05	0.000183	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	9.38e-05	0.000181	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	8.76e-05	0.000169	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	8.65e-05	0.000167	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	7.45e-05	0.000144	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	7.35e-05	0.000142	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	5.61e-05	0.000108	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	5.54e-05	0.000107	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	5.18e-05	9.99e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	5.11e-05	9.87e-05	CbGpPWpGaD
